VYONDYS 53

Indicated For

Duchenne muscular dystrophy (DMD) with confirmed exon 53 amenable mutation

About This Medication

# SareptAssist Patient Guide: How to Get VYONDYS 53 at Low or No Cost VYONDYS 53 (golodirsen) is an FDA-approved exon-skipping therapy for Duchenne muscular dystrophy (DMD) patients with a confirmed mutation amenable to exon 53 skipping. SareptAssist, from Sarepta Therapeutics, helps eligible U.S. patients access this treatment at low or no cost through patient assistance, co-pay support, and personalized case management, especially for uninsured or underinsured individuals.[1][2][6] ## About VYONDYS 53 **VYONDYS 53** treats certain boys with DMD, a rare genetic disorder causing progressive muscle weakness due to dystrophin gene mutations. Administered via **intravenous infusion** weekly, it aims to produce a shortened dystrophin protein to help muscle function. It's approved under accelerated approval based on increased dystrophin levels; ongoing studies verify clinical benefits. Common side effects include hypersensitivity reactions like hives or cough—seek immediate care if these occur. Always consult your doctor for full prescribing information.[5] ## Who Qualifies for SareptAssist? SareptAssist supports U.S. residents (including Puerto Rico) prescribed VYONDYS 53. Key eligibility: - **Uninsured or underinsured** patients (no coverage required).[2][8] - **Needs-based** for those unable to afford therapy.[2] - Commercially insured patients may qualify for **co-pay assistance** to cover deductibles, co-pays, or co-insurance.[1][4] - Must have an FDA-approved DMD diagnosis with exon 53 mutation. Your dedicated **Case Manager** assesses eligibility, explores insurance benefits, and matches you to Sarepta or third-party financial aid programs.[1][4] ## Income Eligibility Breakdown Specific income thresholds aren't publicly detailed, as eligibility is **needs-based** and individualized. Case Managers review household income, assets, insurance status, and expenses. Here's a general overview based on similar programs: | Category | Description | Likely Eligible If... | |----------|-------------|-----------------------| | **Uninsured** | No health insurance | U.S. resident, prescribed VYONDYS 53, meet needs-based criteria[2][8] | | **Underinsured** | High out-of-pocket costs | Insurance denies full coverage or costs exceed affordability[1][2] | | **Commercially Insured** | Private insurance | Eligible for co-pay help (e.g., up to program max); not for government insurance[1][3] | | **Medicare/Medicaid** | Government programs | Limited; explore independent charities via Case Manager[1][4] | | **Income-Based** | Low/moderate income | Household income reviewed case-by-case; no fixed FPL limit published[2] | Contact SareptAssist for your personalized assessment—eligibility isn't guaranteed.[1] ## Insurance Requirements - **No insurance required** for core patient assistance program (PAP), which provides free drug for qualifying uninsured/underinsured.[2][8] - For **co-pay program**, must have **commercial insurance** (not Medicare/Medicaid).[1][3] - Case Manager conducts **benefits investigation** to verify coverage, prior authorizations, or appeals.[1][4] - If insured but 'rendered uninsured' (e.g., coverage denial), PAP may apply.[2][4] - Patient may owe **administration costs** (e.g., infusion fees).[2] ## Step-by-Step Application Process 1. **Get Prescribed**: Discuss VYONDYS 53 with your doctor, confirming exon 53 mutation via genetic testing. 2. **Contact SareptAssist**: Call **1-888-SAREPTA (1-888-727-3782)**, Mon-Fri 8:30am–6:30pm ET, or visit SareptAssist.com. Available for patients/caregivers.[1][4][6] 3. **Complete START Form**: Doctor fills out **SareptAssist START Form** (for exon-skipping therapies like VYONDYS 53). Download from SareptAssist.com.[6] 4. **Submit Form**: Fax to **1-800-621-5203** or email SareptAssist@Sarepta.com.[2][6] 5. **Welcome Call**: Case Manager contacts you to explain benefits, eligibility, and options.[1][4] 6. **Enrollment**: Sign consent for assistance program(s). Case Manager guides through co-pay or PAP enrollment.[1][2] 7. **Approval & Start**: Once approved, coordinate infusion (clinic or home).[1] Spanish forms available.[6] ## Timeline and Delivery - **Processing**: Varies; benefits investigation starts immediately after START Form. Case Manager provides updates.[1][4] - **Approval**: Typically days to weeks, depending on insurance/ docs.[2] - **Delivery**: **Intravenous infusion** at approved centers or home via partners. Case Manager handles logistics.[1] - Ongoing support: Periodic check-ins for refills/reauthorization.[1] ## Alternatives if Denied - **Appeal Insurance Denial**: Case Manager assists with prior authorization appeals.[1] - **Third-Party Charities**: Info on groups like Assistance Fund for DMD.[2][4] - **Other Sarepta Programs**: Co-pay if commercially insured.[1] - **Clinical Trials**: Ask doctor about Sarepta trials. - **State Programs**: Medicaid or local DMD resources via Parent Project Muscular Dystrophy.[10] Reapply if circumstances change. ## Disclaimer This guide summarizes SareptAssist based on available info as of 2026. Eligibility, benefits, and terms can change—contact SareptAssist directly for latest details. Not medical/financial advice; consult your doctor/ advisor. Sarepta doesn't guarantee coverage. See full Prescribing Info for VYONDYS 53 risks.[1][5]

Program information last verified: March 30, 2026